It is with great excitement that we announce the following two individuals as new Partners of Unison Capital effective October 1, 2019:

　Junko Katayanagi
　Tsutomu Kunisawa

Over the last two decades, we have successfully evolved our investment model one transaction at a time. In recent years, our Japan fund has cultivated our sector focused strategy to new heights with our platform-building, practice philosophy. Our new Partners have been an essential part of this growth, particularly in our latest investments in healthcare and consumer industries.

Now with eight Partners in Tokyo and three Partners in Seoul, Unison Capital looks to lead the next decade of private equity investments in Japan/Korea with deep insights and unique local network.

Please direct all inquiries concerning this matter to:
Public Relations
Tel: +81-3-3511-3900

(New Partner Bio)

Junko Katayanagi
Junko Katayanagi joined Unison Capital in 2006. She has been involved in Unison’s investments in Covalent Material, Enoteca, Showa Yakuhin Kako, AYUMI Pharmaceutical, YukoYuko, and LTL. Prior to Unison Capital, she worked at Morgan Stanley, where she was responsible for corporate finance and M&A advisory.

Tsutomu Kunisawa
Tsutomu Kunisawa joined Unison Capital in 2017. He has been a key member of Unison’s recent healthcare investment. Prior to Unison Capital, he worked at Mitsubishi Corporation, Boston Consulting Group, the Development Bank of Japan and the Regional Economy Vitalization Corporation of Japan, where he was involved in corporate finance, asset securitization and private equity investments in the healthcare industry.